Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cells

被引:28
作者
Hegde, NR [1 ]
Jobnson, DC [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA
关键词
D O I
10.1128/JVI.77.17.9287-9294.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The human cytomegalovirus (HCMV) glycoprotein US2 specifically binds to major histocompatibility complex (MHC) class I heavy chain (HC) and class II proteins DRalpha and DMalpha, triggering their degradation by proteasomes. Effects of US2 on class II proteins were originally characterized in HCMV- or adenovirus vector-infected U373 astroglioma cells. Here, we have extended characterization of US2-mediated degradation of class II DRalpha to two other cell lines, including biologically relevant epithelial cells. Comparison of the effects of US2 in cells expressing both class I and II proteins demonstrated only a slight preference for class I HC. Moreover, US2 caused degradation of DRalpha and DMalpha when these proteins were expressed by transfection without DRbeta, invariant chain (Ii), or DMbeta. Therefore, US2 binds to alpha chains of DR and DM and triggers endoplasmic reticulum degradation without formation of class II DR alphabeta/Ii or DM alphabeta complexes. Similar levels of degradation of class II alpha were observed in cells expressing vastly different amounts of class II, suggesting that cellular factors, other than class II, were limiting. We concluded that US2 has broad effects in a variety of cells that express both class I and II proteins and is relevant to HCMV infection in vivo.
引用
收藏
页码:9287 / 9294
页数:8
相关论文
共 54 条
[41]   Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells [J].
Pereboev, AV ;
Asiedu, CK ;
Kawakami, Y ;
Dong, SS ;
Blackwell, JL ;
Kashentseva, EA ;
Triozzi, PL ;
Aldrich, WA ;
Curiel, DT ;
Thomas, JM ;
Dmitriev, IP .
GENE THERAPY, 2002, 9 (17) :1189-1193
[42]   MHC class II-restricted antigen processing and presentation [J].
Pieters, J .
ADVANCES IN IMMUNOLOGY, VOL 75, 2000, 75 :159-208
[43]   Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells [J].
Rehm, A ;
Engelsberg, A ;
Tortorella, D ;
Körner, IJ ;
Lehmann, I ;
Ploegh, HL ;
Höpken, UE .
JOURNAL OF VIROLOGY, 2002, 76 (10) :5043-5050
[44]   Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus [J].
Riegler, S ;
Hebart, H ;
Einsele, H ;
Brossart, P ;
Jahn, G ;
Sinzger, C .
JOURNAL OF GENERAL VIROLOGY, 2000, 81 :393-399
[45]   Association between HLA-DM and HLA-DR in vivo [J].
Sanderson, F ;
Thomas, C ;
Neefjes, J ;
Trowsdale, J .
IMMUNITY, 1996, 4 (01) :87-96
[46]   HLA-A-SPECIFIC AND HLA-B-SPECIFIC MONOCLONAL-ANTIBODIES REACTIVE WITH FREE HEAVY-CHAINS IN WESTERN BLOTS, IN FORMALIN-FIXED, PARAFFIN-EMBEDDED TISSUE-SECTIONS AND IN CRYOIMMUNOELECTRON MICROSCOPY [J].
STAM, NJ ;
VROOM, TM ;
PETERS, PJ ;
PASTOORS, EB ;
PLOEGH, HL .
INTERNATIONAL IMMUNOLOGY, 1990, 2 (02) :113-125
[47]   The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration [J].
Streblow, DN ;
Soderberg-Naucler, C ;
Vieira, J ;
Smith, P ;
Wakabayashi, E ;
Ruchti, F ;
Mattison, K ;
Altschuler, Y ;
Nelson, JA .
CELL, 1999, 99 (05) :511-520
[48]   HIV-1 Nef impairs MHC class II antigen presentation and surface expression [J].
Stumptner-Cuvelette, P ;
Morchoisne, S ;
Dugast, M ;
Le Gall, S ;
Raposo, G ;
Schwartz, O ;
Benaroch, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (21) :12144-12149
[49]   Development and characterization of a binary gene expression system based on bacteriophage T7 components in adenovirus vectors [J].
Tomanin, R ;
Bett, AJ ;
Picci, L ;
Scarpa, M ;
Graham, FL .
GENE, 1997, 193 (02) :129-140
[50]   Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells [J].
Tomazin, R ;
Boname, J ;
Hegde, NR ;
Lewinsohn, DM ;
Altschuler, Y ;
Jones, TR ;
Cresswell, P ;
Nelson, JA ;
Riddell, SR ;
Johnson, DC .
NATURE MEDICINE, 1999, 5 (09) :1039-1043